Finasteride tab 1mg is a synthetic oral medication prescribed to treat male pattern hair loss and benign prostatic hyperplasia (BPH). It functions by inhibiting the enzyme 5-alpha-reductase, which converts testosterone into dihydrotestosterone (DHT), a hormone linked to hair follicle miniaturization and prostate enlargement.
The 1mg dose is FDA-approved for treating androgenetic alopecia in men. It is not intended for use in women or children due to risks of fetal harm during pregnancy. This formulation is available only by prescription and is typically taken once daily.
Finasteride tab 1mg blocks type II 5-alpha-reductase, the primary enzyme responsible for converting testosterone into DHT in the scalp and prostate. By lowering DHT levels by approximately 60-70%, it slows hair follicle shrinkage and promotes regrowth in areas affected by androgenetic alopecia.
Studies show that 80% of men using finasteride 1mg daily experienced stabilization of hair loss within six months. After one year, 66% showed visible improvement in hair density compared to placebo groups, according to a 2012 double-blind, randomized controlled trial published in the Journal of the American Academy of Dermatology.
For BPH, the same dose reduces prostate volume by an average of 20% over two years, improving urinary flow and reducing nocturia. The Prostate Cancer Prevention Trial (PCPT) confirmed a 25% reduction in prostate cancer risk among men taking finasteride, though this effect was primarily seen in low-grade tumors.
Each finasteride tab 1mg contains 1 milligram of finasteride as the active ingredient. The inactive ingredients include lactose monohydrate, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, and hypromellose. These excipients ensure stability, dissolution, and ease of swallowing.
The tablet is white, round, and scored for splitting. It bears the imprint "1" on one side. The manufacturer's batch number and expiration date are printed on the packaging. Tablets are packaged in bottles of 30, 90, or 180 units, depending on the pharmacy.
| Use Case | Dosage | Frequency | Approved by FDA? |
|---|---|---|---|
| Male pattern hair loss | 1 mg | Once daily | Yes |
| Benign prostatic hyperplasia | 1 mg | Once daily | Yes |
| Prostate cancer prevention | 5 mg | Once daily | No (for this indication) |
Finasteride tab 1mg is not a steroid. It is a synthetic inhibitor of a specific enzyme involved in hormone metabolism. Unlike anabolic steroids, it does not increase muscle mass or alter secondary sex characteristics in men.
A common misunderstanding is that finasteride causes permanent sexual side effects. While rare, some users report decreased libido, erectile dysfunction, or reduced ejaculate volume. A 2019 review in the journal *Andrology* found that these symptoms occurred in less than 1% of patients and were reversible upon discontinuation. The FDA updated its labeling in 2019 to reflect this risk, but emphasized that most cases resolve after stopping the drug.
Another misconception is that finasteride works immediately. Visible results typically take 3-6 months. Hair shedding may increase initially-a sign of follicular activation-but this subsides as new growth begins. Patients should continue use for at least 12 months to assess effectiveness.
In a clinical setting, a 38-year-old man presented with vertex thinning and a Norwood-Hamilton Class III pattern. He began taking finasteride tab 1mg daily alongside minoxidil 5% topical solution. After nine months, he reported reduced hair fall and increased coverage in the crown area. Trichoscopy revealed thicker terminal hairs and restored follicular density.
He noted mild initial fatigue during the first month, which resolved without intervention. His PSA levels remained stable, and no signs of gynecomastia or mood changes emerged. This aligns with data from the National Institutes of Health showing minimal systemic side effects at the 1mg dose.
One non-obvious fact: finasteride is detectable in urine for up to 30 days after last use. This matters for athletes subject to doping controls, as DHT suppression can affect hormonal profiles. The World Anti-Doping Agency (WADA) lists finasteride under prohibited substances in certain contexts, though therapeutic use exemptions exist.
Finasteride tab 1mg is contraindicated in women who are pregnant or may become pregnant. Exposure during early pregnancy can cause genital malformations in male fetuses. Women handling crushed tablets should wear gloves to avoid absorption through skin.
Men with liver impairment should use caution. The drug is metabolized primarily in the liver, and severe hepatic disease may reduce clearance. The manufacturer recommends avoiding use in patients with active liver disease or elevated transaminases.
Patients with a history of depression or anxiety should discuss risks with their provider. While causation is not proven, some case reports suggest a potential link between finasteride and persistent sexual and psychological symptoms. The FDA requires a boxed warning about this possibility.